0.9% Sodium Chloride Injection USP, MINI-BAG Plus Container, 100 mL VIAFLEX Single Dose Container...
FDA Drug Recall #D-0861-2016 — Class II — January 21, 2016
Recall Summary
| Recall Number | D-0861-2016 |
| Classification | Class II — Moderate risk |
| Date Initiated | January 21, 2016 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Baxter Healthcare Corp. |
| Location | Deerfield, IL |
| Product Type | Drugs |
| Quantity | 282,080 bags |
Product Description
0.9% Sodium Chloride Injection USP, MINI-BAG Plus Container, 100 mL VIAFLEX Single Dose Container bags, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, Product Code 2B0043, NDC 0338-0553-18.
Reason for Recall
Lack of Assurance of Sterility: potential for leaking containers which lacks the assurance of sterility.
Distribution Pattern
Nationwide and Puerto Rico
Lot / Code Information
Lot #: P337857, Exp 07/31/16
Other Recalls from Baxter Healthcare Corp.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0852-2016 | Class II | Brevibloc DOUBLE STRENGTH Premixed Injection, E... | Apr 12, 2016 |
| D-0731-201 | Class II | 0.9% Sodium Chloride Irrigation, USP, 500 mL bo... | Feb 5, 2016 |
| D-0864-2016 | Class I | CLINIMIX E 5/15 sulfite-free (5% Amino Acid wit... | Jan 21, 2016 |
| D-0862-2016 | Class I | 0.9% Sodium Chloride Injection USP, MINI-BAG Pl... | Jan 21, 2016 |
| D-0863-2016 | Class I | Metronidazole Injection USP, 500 mg per 100 mL ... | Jan 21, 2016 |
Frequently Asked Questions
Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.